Clinical Drug Trial - University of Aberdeen
- University of Aberdeen
- Scotland
- Open procedure
- 23 April 2025 to 1 June 2029
Supply of active drug and identical placebo for a double-blind clinical trial. The scope includes pharmaceutical packaging, labelling, Qualified Person (QP) release, and logistics for shipment to trial sites. The contract duration is tied to the completion of the study, with an initial term of 4 years and potential for four 1-year extensions subject to study requirements and performance review.
- Awarded value
- £70k
- As published
- Published
- 31 October 2024
- Contract length
- 49 months
- Ends 1 June 2029